Service |
ICD number |
Number of cases |
Info |
Mental and behavioural disorders due to use of alcohol |
F10.2 |
250
|
|
Mental and behavioural disorders due to use of alcohol |
F10.0 |
130
|
|
Schizophrenia - Paranoid schizophrenia |
F20.0 |
78
|
|
Reaction to severe stress and adjustment disorders |
F43.2 |
60
|
|
Borderline personality disorder |
F60.31 |
28
|
|
Depressive episode - Major depressive disorder single episode severe without psychotic features |
F32.2 |
26
|
|
Delirium not induced by alcohol and other psychoactive substances |
F05.1 |
24
|
|
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features |
F33.2 |
22
|
|
Vascular dementia |
F01.3 |
20
|
|
Persistent delusional disorders |
F22.0 |
19
|
|
Schizoaffective disorders - Schizoaffective disorder depressive type |
F25.1 |
19
|
|
Delirium not induced by alcohol and other psychoactive substances |
F05.0 |
18
|
|
Mental and behavioural disorders due to use of opioids |
F11.2 |
18
|
|
Depressive episode - Major depressive disorder single episode moderate |
F32.1 |
17
|
|
Mental and behavioural disorders due to use of cannabinoids |
F12.2 |
15
|
|
Depressive episode - Major depressive disorder single episode severe with psychotic features |
F32.3 |
14
|
|
Recurrent depressive disorder - Major depressive disorder recurrent moderate |
F33.1 |
14
|
|
Mental and behavioural disorders due to use of alcohol |
F10.1 |
13
|
|
Schizoaffective disorders - Schizoaffective disorder bipolar type |
F25.0 |
11
|
|
Reaction to severe stress and adjustment disorders |
F43.1 |
11
|
|
Mental and behavioural disorders due to use of cannabinoids |
F12.0 |
10
|
|
Mental and behavioural disorders due to use of cannabinoids |
F12.5 |
10
|
|
Acute and transient psychotic disorders |
F23.1 |
9
|
|
Alzheimer disease - Alzheimers disease with late onset |
G30.1 |
9
|
|
Mental and behavioural disorders due to use of alcohol |
F10.3 |
8
|
|
Schizophrenia - Residual schizophrenia |
F20.5 |
8
|
|
Schizoaffective disorders |
F25.2 |
7
|
|
Mental and behavioural disorders due to use of sedatives or hypnotics |
F13.2 |
6
|
|
Recurrent depressive disorder - Major depressive disorder recurrent severe with psychotic symptoms |
F33.3 |
6
|
|
Other anxiety disorders - Panic disorder episodic paroxysmal anxiety |
F41.0 |
6
|
|
Other mental disorders due to brain damage and dysfunction and to physical disease - Psychotic disorder with delusions due to known physiological condition |
F06.2 |
5
|
|
Bipolar affective disorder - Bipolar disorder current episode depressed severe without psychotic features |
F31.4 |
5
|
|
Mental and behavioural disorders due to use of other stimulants including caffeine |
F15.2 |
4
|
|
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances |
F19.2 |
4
|
|
Bipolar affective disorder |
F31.1 |
4
|
|
Other anxiety disorders |
F41.2 |
4
|
|
Vascular dementia |
F01.2 |
not specified
|
|
Unspecified dementia |
F03 |
not specified
|
|
Other mental disorders due to brain damage and dysfunction and to physical disease |
F06.7 |
not specified
|
|
Mental and behavioural disorders due to use of alcohol |
F10.4 |
not specified
|
|
Mental and behavioural disorders due to use of alcohol |
F10.5 |
not specified
|
|
Mental and behavioural disorders due to use of alcohol |
F10.6 |
not specified
|
|
Mental and behavioural disorders due to use of alcohol |
F10.7 |
not specified
|
|
Mental and behavioural disorders due to use of opioids |
F11.0 |
not specified
|
|
Mental and behavioural disorders due to use of opioids |
F11.1 |
not specified
|
|
Mental and behavioural disorders due to use of cannabinoids |
F12.1 |
not specified
|
|
Mental and behavioural disorders due to use of cannabinoids |
F12.3 |
not specified
|
|
Mental and behavioural disorders due to use of other stimulants including caffeine |
F15.0 |
not specified
|
|
Mental and behavioural disorders due to use of other stimulants including caffeine |
F15.1 |
not specified
|
|
Mental and behavioural disorders due to use of other stimulants including caffeine |
F15.5 |
not specified
|
|
Mental and behavioural disorders due to use of hallucinogens |
F16.0 |
not specified
|
|
Mental and behavioural disorders due to use of hallucinogens |
F16.5 |
not specified
|
|
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances |
F19.5 |
not specified
|
|
Schizophrenia - Disorganized schizophrenia |
F20.1 |
not specified
|
|
Schizophrenia - Undifferentiated schizophrenia |
F20.3 |
not specified
|
|
Schizophrenia - Schizophrenia unspecified |
F20.9 |
not specified
|
|
Acute and transient psychotic disorders |
F23.0 |
not specified
|
|
Acute and transient psychotic disorders |
F23.2 |
not specified
|
|
Acute and transient psychotic disorders |
F23.3 |
not specified
|
|
Acute and transient psychotic disorders |
F23.9 |
not specified
|
|
Schizoaffective disorders - Schizoaffective disorder unspecified |
F25.9 |
not specified
|
|
Manic episode |
F30.1 |
not specified
|
|
Manic episode - Manic episode severe with psychotic symptoms |
F30.2 |
not specified
|
|
Bipolar affective disorder - Bipolar disorder current episode hypomanic |
F31.0 |
not specified
|
|
Bipolar affective disorder - Bipolar disorder current episode manic severe with psychotic features |
F31.2 |
not specified
|
|
Bipolar affective disorder |
F31.3 |
not specified
|
|
Bipolar affective disorder |
F31.7 |
not specified
|
|
Phobic anxiety disorders |
F40.1 |
not specified
|
|
Obsessive-compulsive disorder - Mixed obsessional thoughts and acts |
F42.2 |
not specified
|
|
Reaction to severe stress and adjustment disorders - Acute stress reaction |
F43.0 |
not specified
|
|
Somatoform disorders - Somatization disorder |
F45.0 |
not specified
|
|
Specific personality disorders - Antisocial personality disorder |
F60.2 |
not specified
|
|
Borderline personality disorder |
F60.30 |
not specified
|
|
Mild mental retardation |
F70.1 |
not specified
|
|
Mixed disorders of conduct and emotions |
F92.0 |
not specified
|
|
Other degenerative diseases of nervous system not elsewhere classified |
G31.0 |
not specified
|
|
Medical observation and evaluation for suspected diseases and conditions |
Z03.2 |
not specified
|
|